Dow's 17% plunge and 50% dividend cut reflect deep cyclical challenges, weak margins, and heavy debt. Click here to find out ...

Bursts of euphoric trading are often bullish for near-term returns, but rapid surges in speculation also raise the risk of a ...

Key Points Pandemic-related lockdowns and social restrictions created significant demand for Docusign's digital contract management solutions. Demand tapered off after 2021 when social conditions ...

Netflix stock slips even though the streaming giant reported strong financials for its Q2. But there’s hardly a reason to aggressively buy NFLX shares here.

The S&P 500 index SPX chart is strong and the market internals - while overbought in some cases - generally remain positive. There is now resistance at 6,300, while several support areas are evident: ...

DOCU is down 15% YTD despite solid cash flow and key integrations, but is this a reset or just a stall?

DocuSign (DOCU) closed at $73.55 in the latest trading session, marking a -3.68% move from the prior day. This move lagged the S&P 500's daily loss of 0.33%. Elsewhere, the Dow saw a downswing of 0.63 ...

After rolling through March and April, Lucid stock encountered resistance again in May. Early in the month, the company reported Q1 2025 financial results that jump-started a sell-off in Lucid stock.

Concurrent Investment Advisors LLC purchased a new position in Docusign Inc. (NASDAQ:DOCU – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the ...

Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors July 09, 2025 — 06:15 pm EDT Written by Zacks Equity Research for Zacks -> ...

Futures Movers Oil prices fall as OPEC+ ramps up production; U.S. stock futures decline as tariffs to go into effect Aug. 1 ...

Latest Trump-Musk Battle Spurs $70 Billion Stock Decline for Tesla “I am saddened to watch Elon Musk go completely ‘off the rails,’ essentially becoming a TRAIN WRECK over the past five ...